2nd Pharmacovigilance Audit and Inspection Conference cover
logo 2nd Pharmacovigilance Audit and Inspection Conference
logo 2nd Pharmacovigilance Audit and Inspection Conference

Nobody has claimed this event yet.

Organizers who claim their event pages can update listing details, add photos, answer to reviews, view click reports and more.

Claim your free event listing

Create a Compliant, Effective, and Robust Pharmacovigilance Strategy to Improve Product Quality and Patient Safety

Public International Twice a year or more

Being adequately prepared for pharmacovigilance audit and inspections is crucial to any bio/pharma company committed to maintaining the highest standards of safety and risk management. As regulators increase PV audits and inspections, placing greater scrutiny on PV quality management systems, it's up to the sponsor to assess internal activities, vendor relationships, commercial partnerships, and others that compromise the PV system.This year, at ExL's 2nd Pharmacovigilance Audit and Inspection Conference will focus on the best practices and strategies for those preparing for their audit and inspection, educating PV professionals on new technologies and innovative methods in pharmacovigilance that are emerging, and how to utilize them to improve organizational performance and reporting.

URLs:
Brochure: https://go.evvnt.com/325711-3?pid=5528
Booking: https://go.evvnt.com/325711-4?pid=5528

Speakers: Susan Welsh, Chief Safety Officer, CSL BEHRING, Nusrat Sultani, Associate Director, PV Compliance, Global Patient Safety Evaluation (GPSE) Compliance, TAKEDA PHARMACEUTICALS, Julie Miller, Deputy Director, Audit and Inspection Readiness Manager, SANOFI, Claudia Nolte, Director of PV Quality Assurance (PVQA), CSL BEHRING, Fawad Piracha, Risk Management, Pharmacovigilance/Risk Management, REGENERON PHARMACEUTICALS, INC., Marissa Fernandez, Pharmacovigilance Manager, BAXTER HEALTHCARE CORPORATION, Romana Hosain, Head of Risk Management, REGENERON PHARMACEUTICALS, INC., Suzanne Elliott, Director, MRL QA Pharmacovigilance, MERCK, Kevin P. Malobisky, Senior Vice President Regulatory, Quality, and Pharmacovigilance, KARYOPHARM THERAPEUTICS, Jaylaxmi Nalawade, M.D., Associate Director, Pharmacovigilance and REMS, LUPIN SOMERSET, Katie Driscoll-Alberta, Global Head of Quality; R And D, Pharmacovigilance and Commercial Product Samples, ALKERMES, Deepa Arora, Vice President - Pharmacovigilance and Global Head - Drug Safety and Risk Management, LUPIN LIMITED, Richard Wolf, Senior Director Regions and PV Operations, Global Clinical Safety and Pharmacovigilance, CSL BEHRING, Sameer Thapar, Drug Safety and Pharmacovigilance, TEMPLE UNIVERSITY SCHOOL OF PHARMACY

Time: 8:00 am to 5:00 pm

Practical Info

Prices:
Early Bird Pricing - Before February 8, 2019: USD 1895.0,
Standard Pricing - After February 8, 2019: USD 2095.0

logo 2nd Pharmacovigilance Audit and Inspection Conference
logo user

Share your own experience

2nd Pharmacovigilanc...

Reviews are public and modifiable.

Satisfaction Indicators from ratings shared by attendees

Ratings & Reviews for 2nd Pharmacovigilance Audit and Inspection Conference

Previous Events

  Total Domestic Foreign
Visitors
Exhibitors
Represented firms
Exhibitors' Countries
Sq.M.